spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

High performance range of insulated shipping systems

Laminar Medica


Laminar Medica’s Chilltherm® Global range of high performance insulated shipping systems, from 4 to 1130 litres product volume, are designed to offer optimal thermal protection for pharmaceutical products when exposed to extreme climates from -20°C to +40°C.

These shipping systems are pre-qualified to maintain payload integrity between +2°C and +8°C for transit durations of up to 120 hours. Real live data profiles have been used to give customers confidence that the quality and efficacy of their payloads will not be compromised during even the most demanding external temperatures. Cross hemisphere profile testing makes it ideal for clients making transcontinental shipments.

With only three sizes of cool packs used across the range and a common bill of materials for summer and winter pack outs the impact to warehousing and handling is minimised.

phone 44 (0)14 4282 8664
email enquiries@laminarmedica.co.uk
web www.laminarmedica.com
email Unit 4 Tring Industrial Estate, Icknield Way, Tring, Hertfordshire, HP23 4JX
 
Print this page
Send to a friend
   
spacer
News and Press Releases

How to Export Life Science Products

The life science sector in the UK is about to boom. In the first half of 2014, the industry raised more financing (£734m) than in all of 2013 (£483m). This makes it Europe's top destination for life science funding, dovetailing seamlessly with the government's aim to make the UK a global hub for the sector.
More info >>


White Papers

Working Towards a Standardised Identification Solution

Packaging Coordinators, Inc.

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

Clinical Trial Supply West Coast

2-3 June 2015, San Francisco, USA

The Clinical Supply West Coast 2015conference is celebrating its 8th edition this year. The highly anticipated event will be taking place on 2nd – 3rd of June in San Francisco, USA. This interactive two day conference will provide a unique platform for attendees to discuss relevant topics, hear from leading industry representatives and gain expert knowledge on how to successfully overcome challenges currently facing the clinical supply chain.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement